Trial NCT01697293

View at ClinicalTrials.gov 
Org. Study IDs: 2011-269
Secondary IDs: 007884 11-051 2011-269 NCI-2013-01311 P30CA013330 PTX-200 PTX-200-BC-1501.1 R01CA098473 TCN-PM

Last trial update was posted on 2020-09-24

MeSH Interventions

Albumin-Bound Paclitaxel Cyclophosphamide Doxorubicin Liposomal doxorubicin Paclitaxel

MeSH Conditions

Breast Neoplasms

Other Conditions

Breast Adenocarcinoma Estrogen Receptor Positive HER2/Neu Negative Recurrent Breast Carcinoma Stage IIB Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer

Stopping Reasons

criteria for continuing enrollment in Phase 2 portion was not met

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID